Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_assertion type Assertion NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_head.
- NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_provenance.
- NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_assertion evidence source_evidence_literature NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_provenance.
- NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_assertion SIO_000772 20597268 NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_provenance.
- NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_assertion wasDerivedFrom gad-20150221 NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_provenance.
- NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_assertion wasGeneratedBy ECO_0000203 NP111812.RA9Anhc0IIK79GyDwZ3P10pvA_rDYRNKVQI8_uC_3oHYg130_provenance.